Stimuli-Responsive Nanoplatform to Combine Magnetic Hyperthermia with Immunemodulators Delivery for Glioblastoma Treatment

Project Information

MHT-ImmunoEnhancer

Grant agreement ID: 843838

DOI 10.3030/843838

Project closed

EC signature date 28 March 2019

Start date 1 October 2019

End date 30 September 2021

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 183 473,28

EU contribution € 183 473,28

Coordinated by

FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
Italy

Publications

Peer reviewed articles (2)

Elucidating the Innate Immunological Effects of Mild Magnetic Hyperthermia on U87 Human Glioblastoma Cells: An In Vitro Study

Author(s): Stefano Persano, Francesco Vicini, Alessandro Poggi, Jordi Leonardo Castrillo Fernandez, Giusy Maria Rita Rizzo, Helena Gavilán, Niccolo Silvestri, Teresa Pellegrino
Published in: Pharmaceutics, Issue 13/10, 2021, Page(s) 1668, ISSN 1999-4923
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/pharmaceutics13101668

Magnetic Nanostructures as Emerging Therapeutic Tools to Boost Anti-Tumour Immunity

Author(s): Stefano Persano, Pradip Das, Teresa Pellegrino
Published in: Cancers, Issue 13/11, 2021, Page(s) 2735, ISSN 2072-6694
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers13112735